T.06.4 LONG TERM EFFICACY AND SAFETY OF ABP 501 ADALIMUMAB BIOSIMILAR ON INFLAMMATORY BOWEL DIESASES: THE ADASWITCH STUDY. (May 2022) - Cingolani, A.; Felice, C.; Lombardi, G.; Onidi, F.M.; Checchin, D.; Colucci, R.; Grossi, L.; Ferronato, A.; Rocchi, C.; Ascolani, M.; Binaghi, L.; Dore, M.F.; et al.